|
|
6Arnold L Smith
![]() Summary for 2004 [at-glance overview of Arnold L Smith work for the selected year as suggested by data mining algorithms]This is an Authoratory overview of author Arnold L Smith. According to available data, in 2004 Arnold L Smith published at least 6 articles. This work was completed in collaboration with several authors including Daines, Dayle A and Galperin, Michael Y. Many other authors have collaborated with Arnold L Smith as well. At least 15 different grants are awarded to Arnold L Smith to support this work. All time total of the grant awards on file exceeds $10,447,508.
Arnold L Smith has rank 7 when compared to all other authors using the keyword Haemophilus influenzae. Analysis of the article abstracts and the titles suggests that Arnold L Smith professional interests are focused around "strain rd kw20", "nontypeable haemophilus influenzae" and "pediatric liver transplantation". These might also be referred to as "haemophilus influenzae", "rd kw20" or "nontypeable haemophilus". Statistical analysis shows that Arnold L Smith's writing is likely to contains terms "influenzae", "haemophilus", "dam", "cells", "vapdhi" and "protein".
Unfortunately, there is not enough information to establish Arnold L Smith affiliation. Luckily, one email address is on file. Images [images we found on the Internet for Arnold L Smith]loading...
Do you know Arnold L Smith who matches the profile above? Click the photo and let us know!
Alternative names (1) [other authors with names similar to Arnold L Smith]Year 2004 Charts [Arnold L Smith frequent coauthors and the most common unique vocabulary terms for the selected year]Historical Performance Charts [graphical overview of Arnold L Smith publication and funding history for the range of years]Emails (1) [email addresses extracted from Arnold L Smith affiliations]hidden to prevent spam, click here to reveal Arnold L Smith Coauthors (15) [all coauthors with the number of joint publications] Other [context-specific ads]Affiliations (5) [condensed summary of the Arnold L Smith affiliations, the leading number and the color conveys importance]- 2Seattle Biomedical Research Institute, 307 Westlake Ave N, Suite 500, Seattle, WA 98109, 98109-5219, USA.
1Lawrence Livermore National Laboratory, L-501, 7000 East Avenue, Livermore CA 94550-9698, USA. 1Seattle Biomedical Research Institute, 4 Nickerson St. Suite 200, Seattle, WA 98109, USA. 1Department of Paediatric Gastroenterology and Clinical Nutrition, Royal Children's Hospital, Flemington Road, 3052, Parkville, Melbourne, Victoria, Australia. 1Department of Bioengineering, University of California at San Diego, La Jolla, California, USA.
Key Opinion Leader In [Arnold L Smith is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]- 7Haemophilus influenzae | 10Genetic Complementation Test | 89Genes, Bacterial | 277DNA, Bacterial | 632Bacterial Proteins
Keywords (32) [keywords assigned to Arnold L Smith articles by PubMed, the leading number and the color conveys importance]- 5Haemophilus influenzae | 4Humans | 3DNA, Bacterial | 3Genes, Bacterial | 3Genetic Complementation Test | 3Bacterial Proteins | 2Adenosine Triphosphatases | 2DNA-Binding Proteins | 2MutS DNA Mismatch-Binding Protein | 2Escherichia coli | 2Virulence | 2Mutation | 1Prosthesis Implantation | 1Rats | 1Tricarboxylic Acids | 1Repetitive Sequences, Nucleic Acid | 1Brain | 1Cytoplasm | 1Cystic Fibrosis | 1Cell Division | 1Selection (Genetics) | 1Reverse Transcriptase Polymerase Chain Reaction | 1Epithelial Cells | 1Recombination, Genetic | 1Recombinant Proteins | 1Rifampin | 1Membrane Glycoproteins | 1Ampicillin Resistance | 1Nalidixic Acid | 1Electron Transport | 1Infant | 1Fermentation
Arnold L Smith Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Arnold L Smith might be a good expert witness on these terms]- 23influenzae | 14haemophilus | 14dam | 10cells | 10vapdhi | 9protein | 8strain | 8human | 7muts | 7expression | 7rd | 6identified | 6metabolic | 6survival | 6nontypeable | 5nthi | 5may | 4obstruction | 4phenotype | 4mutants | 4vapxhi | 4within | 4hepatic | 4gene | 4endothelial | 4epithelial | 3known | 3genetic | 3resulted | 3characterization | 3venous | 3outflow
- 12haemophilus influenzae | 7rd kw20 | 5nontypeable haemophilus | 5liver transplantation | 5strain rd | 4endothelial cells | 4protein expression | 3outflow obstruction | 3hepatic venous | 3nthi survival | 3survival within | 3deoxyadenosine methyltransferase | 3methyltransferase dam | 3budd-chiari syndrome | 3pediatric liver | 3rich medium | 3metabolic model | 2dam mutants | 2kw20 strain | 2ectopic delivery | 2truncated protein | 2brain microvascular | 2influenzae metabolic | 2successful stenting | 2influenzae virulence | 2human respiratory | 2mismatch repair | 2attenuates haemophilus | 2identification characterization | 2epithelial cells | 2transplantation case | 2human brain
- 5strain rd kw20 | 3nontypeable haemophilus influenzae | 3pediatric liver transplantation | 3deoxyadenosine methyltransferase dam | 2human respiratory epithelial | 2epithelial cells nci-h292 | 2chronic mucosal infections | 2construction nontypeable haemophilus | 2series review literature | 2successful stenting budd-chiari | 2influenzae-specific ectopic delivery | 2brain microvascular endothelial | 2ectopic delivery vector | 2syndrome pediatric liver | 2dam attenuates haemophilus | 2liver transplantation case | 2haemophilus influenzae putative | 2attenuates haemophilus influenzae | 2budd-chiari syndrome pediatric | 2nontypeable haemophilus influenzae-specific | 2venous outflow obstruction | 2rd kw20 strain | 2hepatic venous outflow | 2epithelial endothelial cells | 2nthi survival within | 2transplantation case series | 2methyltransferase dam attenuates | 2stenting budd-chiari syndrome | 2identification characterization nontypeable | 2inactivation deoxyadenosine methyltransferase | 2dna mismatch repair | 2haemophilus influenzae-specific ectopic
Reader's Comments (0) [comments posted by readers of Arnold L Smith profile]Funding (15) [selected NIH grants to Arnold L Smith and the award amounts for recent years]- PATHOGENESIS OF INVASIVE H INFLUENZAE DISEASE (SMITH, ARNOLD - 1981)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- H INFLUENZAE SURFACE FIBRILS: PATHOGENIC ROLE (SMITH, ARNOLD - 1985)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- SMALL INSTRUMENTATION GRANT (SMITH, ARNOLD - 1990)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- SMALL INSTRUMENTATION GRANT (SMITH, ARNOLD - 1991)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- INVASIVE NONCAPSULATED H. INFLUENZAE (SMITH, ARNOLD - 2000)
| Grant # | Award Year | Award Amount, USD | | 1R01AI044002-01A2 | 2000 | $290,000 | | 5R01AI044002-02 | 2001 | $290,000 | | 5R01AI044002-03 | 2002 | $79,974 | | 7R01AI044002-04 | 2002 | $210,026 | | 5R01AI044002-05 | 2003 | $358,000 | | 5R01AI044002-06 | 2004 | $384,500 | | Total up to 2004 | $1,612,500 |
- VIRULENCE GENES HAEMOPHILUS INFLUENZAE (SMITH, ARNOLD - 2002)
| Grant # | Award Year | Award Amount, USD | | 1R01AI046512-01A1 | 2002 | $1 | | 7R01AI046512-02 | 2002 | $151,875 | | 5R01AI046512-03 | 2003 | $323,750 | | 5R01AI046512-04 | 2004 | $340,833 | | Total up to 2004 | $816,459 |
- ROLE OF PHASE-VARIABLE DNA METHYLASE IN VIRULENCE OF HAEMOPHILUS INFLUENZAE (SMITH, ARNOLD - 2007)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- QUORUM SENSING IN H. INFLUENZAE OTITIS (SMITH, ARNOLD - 2002)
| Grant # | Award Year | Award Amount, USD | | 1R01DC005833-01 | 2002 | $402,750 | | 5R01DC005833-02 | 2003 | $402,750 | | 5R01DC005833-03 | 2004 | $429,750 | | Total up to 2004 | $1,235,250 |
- METABOLISM AND CYSTIC FIBROSIS (SMITH, ARNOLD - 1989)
| Grant # | Award Year | Award Amount, USD | | 5P50DK041978-04 | 1992 | $656,987 | | 5P50DK041978-05 | 1993 | $657,001 | | Total up to 2004 | $1,313,988 |
- DEVELOPMENT AND UTILIZATION OF MICRO-ENZYMATIC ASSAYS (SMITH, ARNOLD - 1977)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- AMINOGLYCOSIDE PHARMACOLOGY IN CHILDREN (SMITH, ARNOLD - 1978)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- DEVELOPMENTAL PHARMACOLOGY CENTER (SMITH, ARNOLD - 1987)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- CSF DURING MENINGITIS (SMITH, ARNOLD - 1972)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- ACADEMIC PEDIATRIC INFECTIOUS DISEASE (SMITH, ARNOLD - 1981)
| Grant # | Award Year | Award Amount, USD | | 2T32HD007233-11 | 1992 | $172,032 | | 5T32HD007233-12 | 1993 | $176,301 | | 5T32HD007233-13 | 1994 | $168,812 | | 5T32HD007233-14 | 1995 | $172,842 | | 5T32HD007233-15 | 1996 | $179,115 | | 2T32HD007233-16 | 1997 | $162,023 | | 3T32HD007233-16S1 | 1998 | $9,558 | | 5T32HD007233-17 | 1998 | $179,210 | | 5T32HD007233-18 | 1999 | $197,195 | | 5T32HD007233-19 | 2000 | $177,450 | | 5T32HD007233-20 | 2001 | $84,676 | | 2T32HD007233-21 | 2002 | $245,892 | | 5T32HD007233-22 | 2003 | $248,551 | | 5T32HD007233-23 | 2004 | $202,323 | | Total up to 2004 | $2,375,980 |
- NOVEL SYNERGISTIC THERAPY FOR CYSTIC FIBROSIS (SMITH, ARNOLD - 1993)
| Grant # | Award Year | Award Amount, USD | | 1R01HL050253-01 | 1993 | $158,018 | | 5R01HL050253-02 | 1994 | $493,758 | | Total up to 2004 | $651,776 |
Arnold L Smith Articles (6) [selected PubMed articles for the year 2004 with the links to a full text at PubMed]Hypermutable Haemophilus influenzae with mutations in mutS are found in cystic fibrosis sputum. (2004) >> Seattle Biomedical Research Institute, 307 Westlake Ave N, Suite 500, Seattle, WA 98109, USA. 2Watson, Michael E, 6Smith, Arnold L, 5Burns, Jane L.Identification and characterization of a nontypeable Haemophilus influenzae putative toxin-antitoxin locus. (2004) >> Lawrence Livermore National Laboratory, L-501, 7000 East Avenue, Livermore CA 94550-9698, USA. 3Daines, Dayle A, 6Smith, Arnold L, 2Jarisch, Justin.Inactivation of deoxyadenosine methyltransferase (dam) attenuates Haemophilus influenzae virulence. (2004) >> Seattle Biomedical Research Institute, 307 Westlake, Suite 500, Seattle, WA 98109-5219, USA. 2Watson, Michael E, 6Smith, Arnold L, 2Jarisch, Justin.Construction of a nontypeable Haemophilus influenzae-specific ectopic delivery vector. (2004) >> Seattle Biomedical Research Institute, 4 Nickerson St. Suite 200, Seattle, WA 98109, USA. 3Daines, Dayle A, 6Smith, Arnold L.Successful stenting for Budd-Chiari syndrome after pediatric liver transplantation: a case series and review of the literature. (2004) >> Department of Paediatric Gastroenterology and Clinical Nutrition, Royal Children's Hospital, Flemington Road, 3052, Parkville, Melbourne, Victoria, Australia. 2Goh, Tiow H, 2Wilkinson, James L, 4Jones, Robert, 2Hardikar, Winita, 6Smith, Arnold L, 2Angus, Peter, 2Rerksuppaphol, Sanguansak.In Silico Metabolic Model and Protein Expression of Haemophilus influenzae Strain Rd KW20 in Rich Medium. (2004) >> Department of Bioengineering, University of California at San Diego, La Jolla, California, USA. 1Tyler, Ryan E, 4Price, Nathan D, 9Palsson, Bernhard O, 1Munson, Robert, 1Akerley, Brian J, 2Raghunathan, Anu, 3Picone, Alex F, 17Galperin, Michael Y, 2Cherny, Tim, 2Reilly, Thomas J, 6Kolker, Eugene, 4Purvine, Samuel, 5Xie, Tao, 7Makarova, Kira S, 6Smith, Arnold L.
Science Trivia (2) [Interactive math & science trivia questions]
|
|